Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| R01HL133254 | Role of S-nitrosylation in Transdifferentiation | 1 | 2021 |
| R01HL136232 | Biomimetic cardiac patch capable of rapid angiogenesis | 1 | 2021 |
| R01HL139757 | Role of flow-sensitive KLK10 in endothelial dysfunction and atherosclerosis | 1 | 2021 |
| R01HL140618 | Engineering highly elastic surgical sealants with hemostatic properties | 1 | 2021 |
| R01MD012767 | Molecular Determinants of Social Factors in Prostate Cancer | 1 | 2021 |
| R01MH097879 | MicroRNA Dysregulation in Pyschiatric Disorders and Cognitive Dysfunction | 1 | 2021 |
| R01MH110427 | OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment Mechanisms | 1 | 2021 |
| R01NS042617 | Tocotrienol Vitamin E Against Stroke | 1 | 2021 |
| R01NS065957 | Ketogenic Diet and Adenosine: Epigenetics and Antiepileptogenesis | 1 | 2021 |
| R01NS100514 | Reprogramming Cell Fate for Repair | 1 | 2021 |
| R01NS100761 | Fetal Tissue Engineering to Treat Spina Bifida Before Birth | 1 | 2021 |
| R15CA161491 | Capsaicin and small cell lung cancer therapy | 1 | 2021 |
| R15CA252997 | Androgen signaling and sterol metabolism in metastatic prostate cancer: Functional and therapeutic implication | 1 | 2021 |
| R21AR077203 | Targeting MicroRNAs for Osteochondral Tissue Engineering | 1 | 2021 |
| R21ES030334 | Alternative splicing in arsenical skin carcinogenesis | 1 | 2021 |
| R21NS114455 | Glioblastoma radioimmunotherapy | 1 | 2021 |
| R37AI051652 | Biomolecular Markers for Safe Minimization of Immunosuppression | 1 | 2021 |
| R37NS027699 | MOLECULAR STUDIES OF SPINOCEREBELLAR ATAXIS TYPE I | 1 | 2021 |
| R56MH127075 | Cell type signaling specificity of the neurodevelopmental disease-associated DYRK1A kinase | 1 | 2021 |
| RF1AG033570 | Plasticity circuits in Alzheimer s disease | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=27